Biologic Drugs: Benefits Outweigh Risks

Biologic drugs, which impact the immune system, carry certain risks, but they are manageable.

Treatment for rheumatoid arthritis changed dramatically more than 20 years ago with the advent of the disease-modifying antirheumatic drug (DMARD) methotrexate. Over the past 15 years, new types of DMARDs, called biologics, have continued to revolutionize treatment. Even newer ones are under development.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access